Exhibit and Poster Hall Hours
Monday, February 23 · 3:15 pm - 6:45 pm
Tuesday, February 24 · 10:15 am - 3:45 pm
Wednesday, February 25 · Closed

IBC主辦之AsiaTIDES囊括從處方到藥物投遞法規之最新動向，是日本唯一與寡核酸(oligonucleotide)及胜肽(peptide)治療戰略相關之活動，會中將針對全球開發現狀，進行廣泛探討。

日本的製藥企業與學術機關之研究人員，對於這個極具未來潛力的寡核酸及胜肽治療領域，特別是siRNA與mRNA適體(aptamer)及其相關分子等熱門領域，抱持高度關注。本次活動將為日本關心此議題的各界人士，介紹全球開發的最新動態。注目焦點包括分析與生物分析技術、研究用RNA/DNA進行商品化時，合成及精製之規模放大，等主題講座。

在主會議中，議題將涵蓋此領域的藥物投遞與處方、包含最佳化與CMC開發前期臨床試驗與測試中化合物之全球相關案例學習、世界法規動向與市場環境、合作關係等。

Keynote Presentations
	Yoshikazu Nakamura, Ph.D. University of Tokyo; Ribomic Japan		Akira Yamada, Ph.D. Kurume University Research Center for Innovative Cancer Therapy Japan
	Junichi Yano, Ph.D. Nippon Shinyaku Co., Ltd. Japan		Takumi Kawabe, M.D., Ph.D. CanBas Japan
Featured Presentations
	Larry Gold, Ph.D. SomaLogic, Inc. USA		Rachel Meyers, Ph.D. Alnylam Pharmaceuticals USA

"AsiaTIDES: A first-of-its-kind meeting in Asia providing valuable insight into this niche area."
- Philip R. Oldfield, Ph.D., Scientific Director, Immunochemistry, Laboratory Sciences, Charles River Laboratories PCS-MTL, Canada

"The concentration of key industry players at TIDES is fantastic; the event is tremendously useful… Almost all the important decision-makers attended TIDES 2008."
- Simon May, Ph.D., Global Director, Business-to-Business Sales, Life Science Research, Thermo Fisher Scientific, United Kingdom

Attendees Praise the U.S. TIDES Conference

"The conference brought nearly all the experts in oligonucleotide therapeutics area under one roof, which made for an educational and entertaining meeting."
- Sumit Lutara, Senior Scientist, Pfizer, Inc, USA

"TIDES conferences in Europe and USA are always great places to learn about all the different aspects of oligonucleotide manufacturing, new diagnostic and therapeutic applications and ideal venues to network with colleagues and customers. I am excited that this great event now also starts in Asia."
- Peter Haima, Ph.D., Manager IVD Services, Eurogentec S.A., Belgium

"I have participated in TIDES since its inception and find it to be by far the most useful meeting in the field, for both the latest updates on drug development and regulatory issues, and also for networking with industry leaders."
- Michael S. Verlander, D. Phil., Executive Vice President, PolyPeptide Laboratories, Inc., USA and India

About the Organizers
This event is brought to you by the organizers of TIDES Peptide and Oligonucleotide® Technology and Product Development and EuroTIDES conferences, as well as Drug Discovery and Development of Innovative Therapeutics World Congress in Boston and Japan, IBC Life Sciences, an informa business. Other informa businesses include: Datamonitor, MedTRACK, SCRIP and Pharmaprojects. www.IBCLifeSciences.com and www.informa.com

Conference Language
The conference will be conducted in English without translation.